Tiziana Life Sciences (TLSA) Receivables - Net (2017 - 2022)

Tiziana Life Sciences has reported Receivables - Net for 6 years, with the latest figure at $300000.0 in Q4 2022.

• On a quarterly basis, Receivables - Net fell 76.94% year-over-year to $300000.0 in Q4 2022; TTM through Dec 2022 was $300000.0, a 76.94% decrease from a year earlier, with the FY2022 full-year figure at $300000.0, down 76.94% from the prior year.
• Receivables - Net was $300000.0 for Q4 2022 at Tiziana Life Sciences, down from $1.3 million in the prior quarter.
• The five-year high for Receivables - Net was $2.5 million in Q2 2020, with the low at $72204.8 in Q2 2018.
• Average Receivables - Net over 5 years is $775822.4, with a median of $466847.4 recorded in 2018.
• The sharpest annual moves came in 2018 and 2020: Receivables - Net slumped 86.61% in 2018, then jumped 693.13% in 2020.
• Over 5 years, Receivables - Net stood at $319118.3 in 2018, then soared by 92.59% to $614576.5 in 2019, then rose by 27.73% to $785000.0 in 2020, then surged by 65.73% to $1.3 million in 2021, then slumped by 76.94% to $300000.0 in 2022.
• The last three Receivables - Net figures came in at $300000.0 (Q4 2022), $1.3 million (Q4 2021), and $785000.0 (Q4 2020), per Business Quant data.